That has very little to do with its performance today. Meeting endpoints for multiple indications and showing promise in many more is what matters right now. The drug works and when it finally gets the right people behind it everyone will see what we already know.
Pro-140 aka leronlimab was invented by Progenics in 1998, 24 years ago. Still zero FDA approvals.
What's captivating is that it takes 5 minutes of "DD" (if I can call this due diligence...laughing) to realize that.
The stock pumpers paid by Cytodyn - they have more pumpers than MDs - have conveniently hidden the fact that PRO140, aka Leronlimab, has been around for a long, long time. Yep, nearly a quarter of a century.
Yet no BP firm seems interested in buying 40 cents shares "on the cheap".
News 
Market Data 
Discover 
AI
